These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
433 related articles for article (PubMed ID: 34239267)
21. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia. Tsatsralt-Od B; Takahashi M; Nishizawa T; Endo K; Inoue J; Okamoto H J Med Virol; 2005 Dec; 77(4):491-9. PubMed ID: 16254981 [TBL] [Abstract][Full Text] [Related]
22. Recognizing the impact of endemic hepatitis D virus on hepatitis B virus eradication. Goyal A; Murray JM Theor Popul Biol; 2016 Dec; 112():60-69. PubMed ID: 27594346 [TBL] [Abstract][Full Text] [Related]
23. Molecular epidemiological and clinical aspects of hepatitis D virus in a unique triple hepatitis viruses (B, C, D) endemic community in Taiwan. Lu SN; Chen TM; Lee CM; Wang JH; Tung HD; Wu JC J Med Virol; 2003 May; 70(1):74-80. PubMed ID: 12629646 [TBL] [Abstract][Full Text] [Related]
24. Addressing hepatitis delta in primary care practices in the US: a narrative review. Kushner T; Andrews RR Curr Med Res Opin; 2024 May; 40(5):813-820. PubMed ID: 38487951 [TBL] [Abstract][Full Text] [Related]
25. [Delta hepatitis: Epidemiology, diagnostic, natural history and treatment]. Loureiro D; Castelnau C; Bed CM; Asselah T Rev Med Interne; 2022 Mar; 43(3):160-169. PubMed ID: 34799189 [TBL] [Abstract][Full Text] [Related]
26. Assembly and infection efficacy of hepatitis B virus surface protein exchanges in 8 hepatitis D virus genotype isolates. Wang W; Lempp FA; Schlund F; Walter L; Decker CC; Zhang Z; Ni Y; Urban S J Hepatol; 2021 Aug; 75(2):311-323. PubMed ID: 33845061 [TBL] [Abstract][Full Text] [Related]
35. Co-expression of markers for hepatitis delta and hepatitis B viruses in human liver. Ryley NG; Heryet AR; Goldin R; Monjardino J; Saldanha J; Fleming KA Histopathology; 1992 Apr; 20(4):331-7. PubMed ID: 1577410 [TBL] [Abstract][Full Text] [Related]
36. Epidemiological and molecular features of hepatitis B and hepatitis delta virus transmission in a remote rural community in central Africa. François-Souquière S; Makuwa M; Bisvigou U; Kazanji M Infect Genet Evol; 2016 Apr; 39():12-21. PubMed ID: 26747245 [TBL] [Abstract][Full Text] [Related]
37. Hepatitis delta in HIV/HBV co-infected patients in Brazil: is it important? Mendes-Correa MC; Gomes-Gouvêa MS; Alvarado-Mora MV; Da Silva MH; Lázari C; Cavalcanti NC; Alonso FK; Carpinelli CC; Uip DE; Pinho JR Int J Infect Dis; 2011 Dec; 15(12):e828-32. PubMed ID: 21999909 [TBL] [Abstract][Full Text] [Related]
38. Clinical effects of NTCP-inhibitor myrcludex B. Cheng D; Han B; Zhang W; Wu W J Viral Hepat; 2021 Jun; 28(6):852-858. PubMed ID: 33599010 [TBL] [Abstract][Full Text] [Related]
39. Hepatitis B and Hepatitis D Viruses: A Comprehensive Update with an Immunological Focus. Sausen DG; Shechter O; Bietsch W; Shi Z; Miller SM; Gallo ES; Dahari H; Borenstein R Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555623 [TBL] [Abstract][Full Text] [Related]
40. Hepatitis D virus: Improving virological knowledge to develop new treatments. Khalfi P; Kennedy PT; Majzoub K; Asselah T Antiviral Res; 2023 Jan; 209():105461. PubMed ID: 36396025 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]